Michael Green, PhD

Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more: brnw.ch/21x1Sht #AACRlymphoma26 @GreenLymphoLab

Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more: brnw.ch/21x1o6g #AACRlymphoma26

Deadline Extended:Submit an abstract by April 6 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). brnw.ch/21x1bbJ #AACRlymphoma26 @GreenLymphoLab

#AACRlymphoma26 chair Michael R. Green invites you to submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with ICML. Learn more: brnw.ch/21x15pZ @GreenLymphoLab

Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more: brnw.ch/21x10Xh #AACRlymphoma26 @GreenLymphoLab

Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more: brnw.ch/21x0OLd #AACRlymphoma26 @GreenLymphoLab

Abstract submissions are open for the AACR/ICML Advances in Malignant Lymphoma meeting!! June 24-27 in Philadelphia. Please retweet. aacr.org/meeting/advanc…

Need PDX models for Lymphoma research? Check out our newest preprint: biorxiv.org/content/10.648… We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm

I would prefer as an author that reviewers have the time they need to review the paper carefully. 4 days does not mean a lot in the life of a study that has taken multiple years.

10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.

This provides an initial framework for understanding spatially resolved cellular ecosystems in DLBCL, highlighting how microenvironment architecture can shape disease biology. But we are just scratching the surface.

Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.

Spatial profiling of diffuse large B-cell lymphoma. I'm happy to share our latest paper, published today in @NatureGenet - a collaborative effort with @IamLinghua. nature.com/articles/s4158…

Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (x.com/PhRMAfoundatio…). 👉👉biorxiv.org/content/10.110…

@ESHaematology Thank you for the invitation to this wonderful conference in such a spectacular location.

Ignition on, this session is all about CAR T. Michael Green (@GreenLymphoLab) dissected mechanisms of CAR T resistance, including factors that impact refractoriness, early & late progression. #ESHCONFERENCES #ESHLYMPHOID2025 Chairs: Veronika Bachanova, Martin Hutchings

@DelgoffeLab Never seen this before, but can't say I'm surprised. Glad you caught it - for now. On the bright side: mimicry is the sincerest form of flattery.

I want to share a harrowing scientific experience, without exposing too many details, to see if any of my Twitter science friends have seen the same. I was asked to review a ms from a low-mid impact journal. The title caught my eye, so I agreed, but was in for a surprise. 1/

Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 months to get an accession number and even longer for data to be released is a curse to research progress. There must be another way.

@IamLinghua @MDAndersonNews I can't think of anyone more deserving. Congratulations!

✨It’s official! I’ve received the letter confirming my #Promotion to Full Professor with Tenure @MDAndersonNews, effective Sep 1, 2025. I’m absolutely thrilled and deeply grateful to everyone who’s been part of this journey. 🧵 #CareerMilestone #WomenInSTEM

Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions focused on the cutting edge of basic and translational research in Lymphoma. @AACR @icmlugano #lmsm